Hostname: page-component-54dcc4c588-42vt5 Total loading time: 0 Render date: 2025-09-19T09:17:11.191Z Has data issue: false hasContentIssue false
  • English
  • Français

Clozapine: prescribing practices in French psychiatric hospitals, multicenter survey on a given day

Published online by Cambridge University Press:  26 August 2025

D. Espeillac ,
E. Queuille  and
R. Klein
D. Espeillac
Affiliation:
Haute-Garonne, Ferrepsy, Toulouse
E. Queuille
Affiliation:
Gironde, CH Charles Perrens, Bordeaux Nord, Association du réseau PIC, Armentieres, France
R. Klein*
Affiliation:
Haute-Garonne, Ferrepsy, Toulouse
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Efficacy of clozapine has now been proven for all symptoms of resistant schizophrenia. Yet it remains underused in view of the prevalence of drug resistance and unevenly prescribed worldwide despite a general trend towards increasing prescribing (Bachmann et al. Acta Psychiatr Scand 2017; 1-15). Data on hospital clozapine prescribing in France are older and single-center (Mercier et al. L’Encéphale 2009; 35, 321-329). Collaboration between a national multi-professional network (pharmacist, general practitioner, psychiatrist) working in various public or private mental health establishments (the PIC network) and a regional psychiatric research federation (FERREPSY Occitanie) has enabled a broad and up-to-date study of practices.

Objectives

To assess the prevalence of clozapine prescribing among patients hospitalised in full-time psychiatry on a given day. To assess the prevalence of clozapine prescribing in inpatients with a diagnosis of non-organic psychotic disorder (ICD 10: F20-F29). To study the characteristics of patients treated, prescribing methods and clinical monitoring.

Methods

A cross-sectional observational study was carried out in December 2023 with teams from establishments belonging to the PIC and/or FERREPSY network who had volunteered.

Results

30 centers took part in the study, with a total of 795 patients included. The average age was 44.1 years (66% men and 34% women). 14.05% of hospitalised patients were receiving clozapine treatment on the day of the survey. 25.07% of patients with a diagnosis of non-organic psychotic disorder were receiving clozapine treatment. 26.83% of clozapine prescriptions were off-label, mainly for patients with mood disorders. 91.94% of patients had had their blood pressure measured in the quarter preceding the survey, and 91.82% had been weighed. Conversely, only 31.94% had their umbilical circumference measured.

Conclusions

This study found that the prevalence of prescribing among patients with non-organic psychotic disorders in the hospital was higher than expected, according to European data on clozapine prescription Further data on outpatient use are still required.

Disclosure of Interest

None Declared

Information

Type
Abstract
Information
European Psychiatry , Volume 68 , Special Issue S1: Abstracts of the 33rd European Congress of Psychiatry , April 2025 , pp. S335
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.